UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 387

Sortiert nach

Combination of Raltitrexed and Oxaliplatin Is an Active Regimen in Malignant Mesothelioma: Results of a Phase II Study

Journal of clinical oncology, 2003-01, Vol.21 (2), p.349-354

2003

Volltextzugriff (PDF)

Phase I–II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma

Annals of oncology, 2002-09, Vol.13 (9), p.1479-1489

2002

Volltextzugriff (PDF)

Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours

British journal of cancer, 1998-10, Vol.78 (8), p.1102-1107

1998

Volltextzugriff (PDF)

Surgery for lung metastases from colorectal cancer: analysis of prognostic factors

Journal of clinical oncology, 1996-07, Vol.14 (7), p.2047-2053

1996

Volltextzugriff (PDF)

Impact of chromogranin A measurement in the work-up of neuroendocrine tumors

Annals of oncology, 2001, Vol.12, p.S79-S82

2001

Volltextzugriff (PDF)

Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial

Leukemia, 2018-02, Vol.32 (2), p.470-478

2018

Volltextzugriff (PDF)

Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy

Journal of clinical oncology, 1998-02, Vol.16 (2), p.725-732

1998

Volltextzugriff (PDF)

Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma

European journal of cancer (1990), 2000-08, Vol.36 (12), p.1514-1521

2000

Volltextzugriff (PDF)

Carcinoma of an unknown primary site: A chemotherapy strategy based on histological differentiation - results of a prospective study

Annals of oncology, 2001-04, Vol.12 (4), p.535-540

2001

Volltextzugriff (PDF)

Le pneumoblastome de l’adulte

Revue des maladies respiratoires, 2010-11, Vol.27 (9), p.1096-1100

2010

Volltextzugriff (PDF)

Current awareness on nutrition and aging 1997

The Journal of nutrition, health & aging, 1997, Vol.1 (3), p.185-188

Ruffié, P

1997

Volltextzugriff (PDF)

Malignant mesothelioma

British journal of cancer, 2001-05, Vol.84 (S2), p.49-50

2001

Volltextzugriff (PDF)

Multimodal approach to the treatment of malignant pleural mesothelioma

Revue des maladies respiratoires, 2006, Vol.23 (4 Pt 3), p.11S77-11S80

Ruffié, P

2006

Volltextzugriff (PDF)

Epithelial tumours of the thymus

British journal of cancer, 2001-05, Vol.84 Suppl 2 (s2), p.51-54

2001

Volltextzugriff (PDF)

Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy?

European journal of cancer (1990), 1998-02, Vol.34 (3), p.347-352

1998

Volltextzugriff (PDF)

Higher doses of α-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesothelioma

European journal of cancer (1990), 1997-10, Vol.33 (11), p.1900-1902

1997

Volltextzugriff (PDF)

4.4 Approche multimodale du traitement du mésothéliome pleural malin

Revue des maladies respiratoires, 2006, Vol.23 (4), p.77-80

Ruffié, P.

2006

Volltextzugriff (PDF)

The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma: a judicious option?

European journal of cancer (1990), 2004-03, Vol.40 (4), p.515-520

2004

Volltextzugriff (PDF)

Beaux Livres

Médecine palliative, 2006-12, Vol.5 (6), p.349-349

Ruffié, P.

2006

Volltextzugriff (PDF)

Phase I, Dose-Finding, and Pharmacokinetic Study of Raltitrexed Combined With Oxaliplatin in Patients With Advanced Cancer

Journal of clinical oncology, 2000-06, Vol.18 (11), p.2293-2300

2000

Volltextzugriff (PDF)

Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung Cancer

The New England journal of medicine, 1993-12, Vol.329 (25), p.1848-1852

1993

Volltextzugriff (PDF)

Tumeurs épithéliales thymiques

Cancer radiothérapie, 2005, Vol.9 (6), p.351-357

2005

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Docetaxel and Irinotecan in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2000-10, Vol.18 (20), p.3545-3552

2000

Volltextzugriff (PDF)

Cancer et environnement: le cas de l’amiante

Oncologie (Paris, France), 2007-06, Vol.9 (5), p.335-339

2007

Volltextzugriff (PDF)

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2636-2644

2003

Volltextzugriff (PDF)

1 – 25 von 387

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(258)
Mit Volltextzugriff
(222)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(201)
Science & Technology
(117)
Life Sciences & Biomedicine
(101)
Male
(88)
Female
(79)
Adult
(67)
Middle Aged
(62)
Biological And Medical Sciences
(59)
Medical Sciences
(52)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(48)
Oncology
(45)
Aged
(41)
Sciences Biologiques Et Medicales
(38)
Lung Neoplasms - Drug Therapy
(35)
Old Medline
(34)
Sciences Medicales
(32)
Cisplatin - Administration & Dosage
(31)
Prognosis
(29)
Combined Modality Therapy
(28)
Chemotherapy
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combination of Raltitrexed and Oxaliplatin Is an Active Regimen in Malignant Mesothelioma: Results of a Phase II Study

Phase I–II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma

Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours

Surgery for lung metastases from colorectal cancer: analysis of prognostic factors

Impact of chromogranin A measurement in the work-up of neuroendocrine tumors

Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial

Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy

Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma

Carcinoma of an unknown primary site: A chemotherapy strategy based on histological differentiation - results of a prospective study

Le pneumoblastome de l’adulte

Current awareness on nutrition and aging 1997

Malignant mesothelioma

Multimodal approach to the treatment of malignant pleural mesothelioma

Epithelial tumours of the thymus

Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy?

Higher doses of α-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesothelioma

4.4 Approche multimodale du traitement du mésothéliome pleural malin

The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma: a judicious option?

Beaux Livres

Phase I, Dose-Finding, and Pharmacokinetic Study of Raltitrexed Combined With Oxaliplatin in Patients With Advanced Cancer

Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung Cancer

Tumeurs épithéliales thymiques

Phase I and Pharmacokinetic Study of Docetaxel and Irinotecan in Patients With Advanced Solid Tumors

Cancer et environnement: le cas de l’amiante

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Suchergebnisse filtern